Stay updated on Ruxolitinib for Eosinophilic Disorders Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.

Latest updates to the Ruxolitinib for Eosinophilic Disorders Clinical Trial page
- CheckyesterdayChange DetectedThe Study Details page for NCT03801434 now returns a 403 error, blocking access to the trial information and standard navigation.SummaryDifference0.5%

- Check8 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden error, replacing the study details with an error page. The HTML shows a 403 page instead of the expected ClinicalTrials.gov content.SummaryDifference19%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRecruitment status updated to Active, not recruiting, indicating no current enrollment. Stanford University is listed as sponsor and ASCO as a collaborator, and multiple principal investigator contact details were removed.SummaryDifference2%

- Check29 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page's content or metadata on ClinicalTrials.gov.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page shows an updated Revision: v3.6.5, signaling a new site version. This update appears to be a backend or template change rather than a modification to the study information.SummaryDifference0.1%

- Check65 days agoChange DetectedThe revision label at the bottom of the page was updated from v3.6.3 to v3.6.4, signaling a small maintenance update rather than a substantive change to study information.SummaryDifference0.1%

Stay in the know with updates to Ruxolitinib for Eosinophilic Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.